New test: ZEB2 testing for Mowat-Wilson syndrome

We are now offering full gene sequencing and deletion/duplication analysis for Mowat-Wilson syndrome.  Mowat-Wilson syndrome is characterized by distinctive facial features, which in young children include hypertelorism, medially flared and broad eyebrows, prominent or pointed chin, uplifted earlobes and an opened mouth expression.  Individuals with MWS also present with moderate-to-severe mental retardation, seizures and microcephaly.  Congenital anomalies are also common, including Hirschsprung disease, genitourinary anomalies, congenital heart defects, agenesis of the corpus callosum and

Expanded Infantile Spasms/Encephalopathy Panel

Infantile spasms involve momentary flexion of the neck, trunk, or extremities, onsetting within the first year of life and subsiding during late infancy.  Affected children may develop other seizures and have severe developmental delays.  West syndrome is the triad of infantile spasms, hypsarrhythmia, and severe mental retardation.  Early onset and congenital forms of Rett syndrome include infantile spasms or early-onset epileptic seizures.

Now offering MS-MLPA for Angelman and Prader-Willi syndrome testing

Our lab is now performing methylation-specific (MS) MLPA for Angelman and Prader-Willi syndromes.  This testing will identify patients with abnormal methylation, large deletions and imprinting center deletions.  Those patients with abnormal methylation, but no deletion, should pursue UPD testing for UPD15.  Angelman syndrome patients with normal methylation should consider sequencing for UBE3A.  This testing eliminates the need for additional FISH testing or imprinting center testing for these patients.

New Microcephaly Tier 2 Panel Available

We are now offering full gene sequencing of the five known genes for autosomal recessive primary microcephaly (MCPH).  Autosomal recessive primary microcephaly (MCPH) is characterized by congenital microcephaly, mental retardation (but no other neurological findings), normal or mildly short stature, and normal weight and appearance.  Mutations in the ASPM gene are the most common cause of MCPH.  Approximately 40% of patients (both consanguineous and non-consanguineous) with a strict diagnosis of MCPH have mutations in ASPM.  A small number of families with MCPH have been r

MS-MLPA for Angelman syndrome

Institutional Price 
$525

We recommend methylation-specific (MS)-MLPA as the initial test for Angelman and Prader-Willi syndromes.  This testing will identify patients with abnormal methylation, large deletions and imprinting center deletions.  Those patients with abnormal methylation, but no deletion, should pursue UPD testing for UPD15.  Angelman syndrome patients with normal methylation should consider sequencing for UBE3A.

CPT Code 
TAT 
Disorders